Subtype
Urinary Tract Neoplasm
CI-CAN-00001627Explore in graph →
Non-malignant558 active trials14 approved drugs29 evidence items
Loading cancer entity…
Subtype
CI-CAN-00001627Explore in graph →
Clinical trials
2,186 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04155359 | Clinical Evaluation of the miR Sentinel BCa™ Test to Diagnose Bladder Cancer in Hematuria Patients | unknown | — | 444 | miR Scientific LLCINDUSTRY | 1 | Oct 25, 2023 | clinicaltrials |
| NCT05259319 | Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT)(IMMUNOs-SBRT) | unknown | Phase 1 | 92 | Centre Georges Francois LeclercOTHER |
| 1 |
| Oct 17, 2023 |
| clinicaltrials |
| NCT05176145 | Demonstration of the Medical Interest of the VisioCyt® Artificial Intelligence Test(DMIA) | unknown | N/A | 400 | VitadxOTHER | 3 | Oct 13, 2023 | clinicaltrials |
| NCT06074484 | A Study of RC48-ADC Combined With AK104 For Perioperative Treatment of Muscle-Invasive Bladder Cancer | unknown | Phase 2 | 36 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT05220189 | PENK Methylation Test for Detecting Bladder Cancer | unknown | — | 1,549 | Asan Medical CenterOTHER | 1 | Oct 4, 2023 | clinicaltrials |
| NCT05975151 | Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer | unknown | Phase 2 | 63 | Qilu Hospital of Shandong UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06046469 | Validity of Computed Tomography Versus Magnetic Resonance Imaging in Predicting Muscular Invasion of Bladder Cancer | unknown | N/A | 55 | Menoufia UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06033040 | Medical Imaging in Bladder Tumors by MRI | unknown | — | 178 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT06034015 | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy Volunteers | unknown | Phase 1 | 48 | Jiangsu Yahong Meditech Co., Ltd aka AsierisINDUSTRY | 1 | Sep 13, 2023 | clinicaltrials |
| NCT06009848 | Cadonilimab Plus Nab-Paclitaxel for Recurrent or Metastatic Muscle Invasive Bladder Cancer | unknown | Phase 2 | 20 | Tianjin Medical University Second HospitalOTHER | 1 | Aug 24, 2023 | clinicaltrials |
| NCT06005116 | [68Ga] NOTA-SGC8 in the Staging of Bladder Cancer | unknown | N/A | 64 | RenJi HospitalOTHER | 1 | Aug 22, 2023 | clinicaltrials |
| NCT05824299 | Influence of Anesthesia Methods on CTCs in TURBT Patients | unknown | N/A | 162 | RenJi HospitalOTHER | 1 | Aug 9, 2023 | clinicaltrials |
| NCT05462392 | Robot-assisted Urological Surgeries Using the MicroHand S Robot | unknown | N/A | 136 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Aug 2, 2023 | clinicaltrials |
| NCT05739812 | The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery | unknown | N/A | 100 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Jul 14, 2023 | clinicaltrials |
| NCT05912205 | Disitamab Vedotin Combined With Radiotherapy for Bladder Preservation | unknown | Phase 2 | 30 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 0 | Jun 22, 2023 | clinicaltrials |
| NCT02948543 | Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer(BCG+MM) | unknown | Phase 3 | 501 | University of SydneyOTHER | 2 | Jun 18, 2023 | clinicaltrials |
| NCT05895864 | Utidelone Treated for the Recurrent or Metastatic Urothelial Carcinoma | unknown | Phase 2 | 34 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jun 9, 2023 | clinicaltrials |
| NCT05893316 | UroCAD for Hematuria Evaluation--A Prospective, Multi-center Study | unknown | — | 1,000 | Changhai HospitalOTHER | 1 | Jun 7, 2023 | clinicaltrials |
| NCT05885204 | RARC vs LRC in A Multicenter Cohort Study | unknown | — | 3,815 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Jun 1, 2023 | clinicaltrials |
| NCT05823246 | Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma | unknown | Phase 2 | 66 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | May 26, 2023 | clinicaltrials |
| NCT04948528 | Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for Upper Tract Urothelial Carcinoma Detection | unknown | — | 490 | AnchorDx Medical Co., Ltd.INDUSTRY | 1 | May 24, 2023 | clinicaltrials |
| NCT05856825 | Long-Term Outcomes of Robot-Assisted Radical Cystectomy: A Real-World Study | unknown | — | 4,500 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | May 12, 2023 | clinicaltrials |
| NCT04391790 | MOdified Urinary Conduit to Lower Strictures After radIcal Cystectomy(MOSAIC) | unknown | N/A | 300 | Jørgen Bjerggaard JensenOTHER | 1 | Apr 27, 2023 | clinicaltrials |
| NCT05833997 | Safety Analysis and Oncological Outcomes in HoLERT vs TURBT | unknown | N/A | 100 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Apr 27, 2023 | clinicaltrials |
| NCT01675219 | Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9) | unknown | Phase 3 | 400 | Turku University HospitalOTHER_GOV | 1 | Apr 13, 2023 | clinicaltrials |
| NCT05084586 | Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation | unknown | N/A | 100 | Ankara Training and Research HospitalOTHER | 1 | Mar 28, 2023 | clinicaltrials |
| NCT05787938 | Role of MRI in Assessment of the Urinary Bladder Wall Post Transurethral Tumor Resection | unknown | — | 58 | Assiut UniversityOTHER | 0 | Mar 28, 2023 | clinicaltrials |
| NCT04543110 | Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC(RADIANT) | unknown | Phase 2 | 16 | Ottawa Hospital Research InstituteOTHER | 1 | Mar 23, 2023 | clinicaltrials |
| NCT05775874 | A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC | unknown | Phase 2 | 80 | Abbisko Therapeutics Co, LtdINDUSTRY | 1 | Mar 20, 2023 | clinicaltrials |
| NCT04565275 | A Study of ICP-192 in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 45 | Beijing InnoCare Pharma Tech Co., Ltd.INDUSTRY | 2 | Mar 14, 2023 | clinicaltrials |
| NCT05767528 | Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection | unknown | — | 40 | Chinese PLA General HospitalOTHER | 1 | Mar 14, 2023 | clinicaltrials |
| NCT05429866 | Immunological Variables Associated to ICI Toxicity in Cancer Patients | unknown | Phase 2 | 441 | Jules Bordet InstituteOTHER | 1 | Mar 8, 2023 | clinicaltrials |
| NCT03475953 | A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors(REGOMUNE) | unknown | Phase 1 / Phase 2 | 747 | Institut BergoniéOTHER | 1 | Mar 3, 2023 | clinicaltrials |
| NCT04799847 | Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine | unknown | Phase 1 / Phase 2 | 161 | LintonPharm Co.,Ltd.INDUSTRY | 1 | Feb 13, 2023 | clinicaltrials |
| NCT05723991 | Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma | unknown | Phase 4 | 36 | Chunguang yang (101937)OTHER | 1 | Feb 13, 2023 | clinicaltrials |
| NCT05643807 | Bladder Washing Cytology for Detection of Urothelial Carcinoma Using Catheter or Flexible Cystoscope: Which is Better?(BWash) | unknown | N/A | 414 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Feb 10, 2023 | clinicaltrials |
| NCT05508568 | A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer | unknown | — | 650 | Arquer Diagnostics LtdINDUSTRY | 1 | Feb 1, 2023 | clinicaltrials |
| NCT05697224 | Aschistosoma Haematobiumspecific microRNAas a Tumor Marker for Early Diagnosis and Prognosis of Bilharzial Bladder Cancer in Eygpt | unknown | N/A | 50 | Sohag UniversityOTHER | 0 | Jan 25, 2023 | clinicaltrials |
| NCT05445648 | Comprehensive Bladder Preservation Therapy on Patients With Muscle Invasive Bladder Cancer(CBPTMI) | unknown | Phase 2 | 65 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Dec 28, 2022 | clinicaltrials |
| NCT05611762 | Narrow-band Imaging Diagnostic Classification System for Bladder Tumors(NBI) | unknown | — | 1,064 | Qilu Hospital of Shandong University (Qingdao)OTHER | 1 | Dec 19, 2022 | clinicaltrials |
| NCT04730219 | Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Carcinoma | unknown | Phase 2 | 48 | Tianjin Medical University Second HospitalOTHER | 1 | Nov 30, 2022 | clinicaltrials |
| NCT05480735 | EffectiveNess of a Multimodal preHAbilitation Program in patieNts With Bladder canCEr Undergoing Cystectomy(ENHANCE) | unknown | N/A | 154 | The Netherlands Cancer InstituteOTHER | 1 | Oct 31, 2022 | clinicaltrials |
| NCT03529890 | Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder(RACE IT) | unknown | Phase 2 | 33 | Technical University of MunichOTHER | 1 | Oct 20, 2022 | clinicaltrials |
| NCT05564897 | Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer | unknown | Phase 2 | 25 | Zhejiang Cancer HospitalOTHER | 1 | Oct 4, 2022 | clinicaltrials |
| NCT05038657 | Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC).(AURORA) | unknown | Phase 2 | 36 | University Hospital Southampton NHS Foundation TrustOTHER | 1 | Oct 3, 2022 | clinicaltrials |
| NCT05559177 | An Open, Dose-escalation Clinical Study of Chimeric Exosomal Tumor Vaccines for Recurrent or Metastatic Bladder Cancer | unknown | Early Phase 1 | 9 | Shanghai Pudong HospitalOTHER | 1 | Sep 29, 2022 | clinicaltrials |
| NCT05503563 | A Proposed Tetra-modal Treatment Protocol for Muscle Invasive Urothelial Carcinoma of the Urinary Bladder | unknown | — | 50 | Assiut UniversityOTHER | 1 | Aug 16, 2022 | clinicaltrials |
| NCT03844256 | A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study(CRIMI) | unknown | Phase 1 / Phase 2 | 50 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Aug 12, 2022 | clinicaltrials |
| NCT03934827 | MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour(MICROBIOME) | unknown | Phase 1 | 120 | Imperial College LondonOTHER | 1 | Aug 11, 2022 | clinicaltrials |
| NCT04282876 | Influence of Hormone Treatment in Radiation Therapy for Bladder Cancer | unknown | — | 60 | Aarhus University HospitalOTHER | 1 | Aug 8, 2022 | clinicaltrials |
Data updated 22 days agoSource updated Oct 25, 2023source: clinicaltrials